Drug intelligence / Profile preview

Curacen

Development stage
Unknown
Lead developer
Japan Bio Products
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intramuscular, Topical, Oral
01

Overview

Curacen is a cosmetic and aesthetic biologic product developed by Japan Bio Products (JBP). It is composed of human placenta extract (hydrolyzate), which contains a rich array of bioactive substances including cell growth factors (such as EGF, FGF, CSF, IGF, NGF, and TGF-beta), interleukins, amino acids, vitamins, peptides, and minerals. The product is designed to promote skin rejuvenation, reduce wrinkles, and improve skin texture and tone by stimulating the production of collagen and elastin and enhancing cellular regeneration. Curacen is available in multiple formulations, including an injectable for mesotherapy, a topical essence, and oral capsules. It is manufactured using high-purification technology to ensure safety and bioavailability, leveraging the same pharmaceutical expertise used for the liver function drug Laennec.

Brand names
CuracenCuracen EssenceCuracen P.O.+
Other names
human placenta extracthuman placenta hydrolyzate
02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)TGFBR1/2 (Transforming growth factor-beta receptor type 1 and Transforming growth factor-beta receptor type 2)EGFR T790M (Epidermal growth factor receptor T790M mutant)FGFR (FGFR family)

Beyond the preview

Go deeper on Curacen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curacen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call